PSI™ Applied to Autoimmune Progression and Precise Therapeutic Targeting

Learn how PSI can help you characterize critical functional subsets of innate immune cells in multiple sclerosis patients to understand novel targets and advance therapy development.

Unlock Resource
Download this free resource and gain access to our full resource library!

Unlock All Resources

We will always keep your personal information safe. Complete this form to get unlimited access to all of our web resources and join over 10,000 leading researchers who receive industry pioneers' backed data straight to their inbox. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.

fierce innovation award
red dot award winner
scientist award

Role of innate immunity in Multiple Sclerosis pathogenesis requires further understanding

See how IsoPlexis’ Polyfunctional Strength Index (PSI) can be used to assess cytokine secretion of single innate immune cells, i.e. monocytes, in autoimmune patients to monitor progression.

In this Application Highlight we discuss:
  • Demonstrate the value of PSI to reveal functional heterogeneity of single innate immune cells
  • Show that by detecting highly dysfunctional cell subsets, PSI can lead to the unique detection of key patient differences in autoimmune progression
  • Demonstrate how these differences can reveal critical therapeutic insight and novel targets
2019-11-16T10:33:08-05:00